Terran Biosciences' 2025 Prodrug Outlook
Source: Life Science Leader
By Ben Comer, Chief Editor, Life Science Leader
Terran Biosciences' founder and CEO Sam Clark talks about big opportunities for prodrug development in 2025, the importance of a strong medicinal chemistry team, and a potential increase in M&A activity this year.
This website uses cookies to ensure you get the best experience on our website. Learn more